Suppr超能文献

131碘治疗的甲状腺功能亢进患者体重指数与外照射的关系

Relationship between body mass index and external exposure in hyperthyroid patients treated with iodine-131.

作者信息

Yazdanpanah Ghazal, Nematdar Mohammad, Talebian Hoda, Shabestani Monfared Ali

机构信息

Student Research Committee, Babol University of Medical Sciences Babol, Iran.

Department of Medical Physics Radiobiology and Radiation Protection, School of Medicine, Babol University of Medical Sciences Babol, Iran.

出版信息

Am J Nucl Med Mol Imaging. 2022 Jun 15;12(3):99-105. eCollection 2022.

Abstract

We performed this study to evaluate the correlation between Body Mass Index (BMI) and Exposure Rate (ER) of hyperthyroid patients treated with iodine-131 so that in case of any relationship, we can improve the prescribed dose for the treatment of hyperthyroid patients and its side effects on the body and the environment. In this analytical and cross-sectional study, 30 patients with hyperthyroidism treated with liquid iodine-131 were randomly selected. We recorded demographic indicators (age, height, and weight) and ER. Patients were treated with the activity of 8-29 mCi (mean 14.4 mCi) oral I-131. The external radiation of patients was measured from a distance of one meter parallel to the patient's thyroid gland at intervals of 6 to 24 hours post-iodine-131 administration. ER measurements and other acquired data were statistically analyzed by R software and its methods. Data were normalized using the Shapiro method, and due to the non-normality of the data in the correlation test, the Spearman method was used. The measurements of this study represent two main findings: 1. There is a significant relationship between ER and iodine-131 activity because the observed significance level (-value =0.002) is smaller than the predicted error value (0.01). 2. There is no significant relationship between ER and BMI because the observed significance level (-value =0.082) is greater than the predicted error value (0.05). The present study's findings show a negative relationship between BMI and ER. Still, since the -value is more than 0.05, this relationship is not statistically significant.

摘要

我们开展这项研究以评估体重指数(BMI)与接受碘 - 131治疗的甲状腺功能亢进患者的暴露率(ER)之间的相关性,以便在存在任何关联的情况下,我们能够改进甲状腺功能亢进患者治疗的规定剂量及其对身体和环境的副作用。在这项分析性横断面研究中,随机选取了30例接受液态碘 - 131治疗的甲状腺功能亢进患者。我们记录了人口统计学指标(年龄、身高和体重)以及暴露率。患者接受8 - 29毫居里(平均14.4毫居里)的口服I - 131活性治疗。在碘 - 131给药后6至24小时的间隔时间,从与患者甲状腺平行的一米距离处测量患者的外部辐射。暴露率测量值和其他获取的数据通过R软件及其方法进行统计分析。数据使用夏皮罗方法进行归一化,并且由于相关性检验中数据的非正态性,使用了斯皮尔曼方法。本研究的测量结果呈现出两个主要发现:1. 暴露率与碘 - 131活性之间存在显著关系,因为观察到的显著性水平(P值 = 0.002)小于预测误差值(0.01)。2. 暴露率与体重指数之间不存在显著关系,因为观察到的显著性水平(P值 = 0.082)大于预测误差值(0.05)。本研究结果表明体重指数与暴露率之间存在负相关关系。然而,由于P值大于0.05,这种关系在统计学上并不显著。

相似文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验